Topic: Merck & Co. Inc.
The Merck & Co. executive who successfully led the company's legal strategy over the Vioxx recall was named CEO on Tuesday.. Kenneth C. Frazier will succeed Richard T. Clark on Jan. 1. At the time, the move to president of the company ...
In 1837, Hans Christian Andersen authored a short tale titled The Emperor's New Clothes. Despite ample evidence that pan-PI3K inhibitors and dual PI3K/mTOR inhibitors might offer a therapeutic advantage, tailors continue to weave new compounds targeting individual components of the pathway with ...
Richard Clark is the CEO of Merck , a large pharmaceutical company headquartered in <a href=" Clark was announced as the company's CEO on May 5 , 2005 . Named the president and CEO of Merck & Co. 2007 :
Nov. 12--To the casual observer, the pharmaceutical industry these days may appear to be engaged in a mammoth game of Monopoly.. Johnson & Johnson offers $2.3 billion for Crucell NV (September); Pfizer Inc. swallows King Pharmaceuticals Inc. for $3.6 billion (October); Eli ...
Pfizer Inc. in January paid $68 billion to acquire its rival Wyeth, the largest pharmaceutical merger since Glaxo Wellcome PLC bought SmithKline Beecham PLC in 2000. Six weeks after the Pfizer deal, Merck & Co. announced that it would buy Schering-Plough Corp. ...
Back in September, I wrote about Merck & Co. Inc.'s (NYSE: TEVA) regarding the anti-brain cancer drug temozolomide, which Merck (via its Schering subsidiary) markets under the brand name Temodar and which Teva (through its subsidiary Barr) wants to sell generically. Today, ...
Research and development (R&D) plays an integral role in the success of pharmaceutical firms. According to a study conducted by Booz & Co, the healthcare industry had R&D expenditures of over $111 billion in 2009. R&D in Healthcare After analyzing R&D spending ...
Drugmaker Merck's 3Q profit plunges 90 percent on charges from Schering-Plough acquisitionMerck & Co. posts an 90 percent drop in third-quarter profit, due to large charges for its $41.1 billion acquisition of Schering-Plough Corp.The world's second-biggest drugmaker by revenue had net income ...
According to IMS Health, the global market for pharmaceuticals is expected to grow at an annual rate of 5 to 8 percent and reach $1.1 trillion by the year 2014. RV based on historical ratios of the company aloneRV based on historical ...
Wall Street looked set to open lower as investors mulled Pfizer Inc.'s $3.6 billion purchase of King Pharmaceuticals and awaited the release of minutes from the Federal Reserve's September policy meeting and earnings from tech bellwether Intel Corp. See Indications for more ...
Photo Gallery
From Around the Web
Video Gallery
-
Merck & Co. Inc. Dassault Falcon 900EX
N663MK (cn 094) This is my 2500th video uploaded here ...2008-10-07 -
Merck & Co. and Two Academic Institutions ...
Merck & Co. Inc announced that the company will take part ...2011-07-15 -
News Update: Merck & Co., Inc. to ...
Merck & Co., Inc. (NYSE:MRK) will shut down 16 facilities ...2010-07-08
